Ann: Lumos Receives US FDA Clearance for FebriDx, page-280

When trying to re-evaluate share price now, the equation needs to begin with the difference in sp prior to the initial FDA failure and the present price.

This in itself tells me the present rise is going to rise significantly in the near term. It won't go up every day, but will in general.

But this of course wouldn't happen if the main ducks were in line. The fact that Fdx only brings moderate income outside the US is not the principle marker of the potential new cash flow now that the market has suddenly opened in the US. High tides rise all boats. But it is the very significant US market that will bring in the cash.

Then there is the Vdx that will come to market when/if approved by FDA soon. It is likely to succeed due to lessons learnt from Fdx and the fact that it ha sbeen approved in Canada.

Anyway, another day in it before moderating.